CHEMBL1276927

CAS No. 305357-89-5

CHEMBL1276927 ( N-[3-(1H-benzimidazol-2-yl)phenyl]-3-methylbenzamide; N-(3-(1H-benzo[d]imidazol-2-yl)phenyl)-3-methylbenzamide )

Catalog No. M28538 CAS No. 305357-89-5

CHEMBL1276927 shows antibacterial and antiparasitic activities against Chlamydia pneumoniae and Leishmania donovani.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 282 Get Quote
25MG 515 Get Quote
50MG 734 Get Quote
100MG 972 Get Quote
500MG 1971 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CHEMBL1276927
  • Note
    Research use only, not for human use.
  • Brief Description
    CHEMBL1276927 shows antibacterial and antiparasitic activities against Chlamydia pneumoniae and Leishmania donovani.
  • Description
    CHEMBL1276927 shows antibacterial and antiparasitic activities against Chlamydia pneumoniae and Leishmania donovani.
  • Synonyms
    N-[3-(1H-benzimidazol-2-yl)phenyl]-3-methylbenzamide; N-(3-(1H-benzo[d]imidazol-2-yl)phenyl)-3-methylbenzamide
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    305357-89-5
  • Formula Weight
    327.4
  • Molecular Formula
    C21H17N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=CC(=C1)C2=NC=3C=CC=CC3N2)C4=CC=CC(=C4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Antibiotic-5d

    A synthetic antimicrobial compound that antibacterial activity in vitro against various Gram-positive and Gram-negative bacteria, fungi and yeast.

  • Tyrphostin AG 528

    Tyrphostin AG 528 is an inhibitor of EGFR (IC50: 4.9 μM) and ErbB2 (IC50: 2.1 μM).

  • Nevadensin

    Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM. Nevadensin has a variety of pharmacological effects such as anti-mycobacterium tuberculosis activities, antitussive, anti-inflammatory and anti-hypertensive.